Xu Shan-Jing, Ye Li-Ping, Wang Wei, Chen Ya-Hong, Dong Jian, Mao Xin-Li, Li Shao-Wei
Shaoxing University School of Medicine, Shaoxing, Zhejiang, China.
Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Stem Cells Int. 2021 Nov 16;2021:5513309. doi: 10.1155/2021/5513309. eCollection 2021.
Liver disease is a severe health problem that endangers human health worldwide. Mesenchymal stem cell (MSC) therapy is a novel treatment for patients with different liver diseases due to its vast expansion potential and distinctive immunomodulatory properties. Despite several preclinical trials having confirmed the considerable efficacy of MSC therapy in liver diseases, the questionable safety and efficacy still limit its application. As a precursor cell, MSCs can adjust their characteristics in response to the surrounding microenvironment. The microenvironment provides physical and chemical factors essential for stem cell survival, proliferation, and differentiation. However, the mechanisms are still not completely understood. We, therefore, summarized the mechanisms underlying the MSC immune response, especially the interaction between MSCs and the liver microenvironment, discussing how to achieve better therapeutic effects.
肝脏疾病是一个严重的健康问题,在全球范围内危及人类健康。间充质干细胞(MSC)疗法因其巨大的扩增潜力和独特的免疫调节特性,是一种针对不同肝脏疾病患者的新型治疗方法。尽管多项临床前试验已证实MSC疗法在肝脏疾病中具有显著疗效,但其安全性和有效性仍存在疑问,这限制了其应用。作为一种前体细胞,间充质干细胞可以根据周围微环境调整其特性。微环境提供了干细胞存活、增殖和分化所必需的物理和化学因素。然而,其机制仍未完全明确。因此,我们总结了间充质干细胞免疫反应的潜在机制,特别是间充质干细胞与肝脏微环境之间的相互作用,探讨如何实现更好的治疗效果。